Professional and Reliable IHC Raw Antibody Solutions for Lung Pathology
Lung tissue presents significant challenges in adenocarcinoma versus squamous cell carcinoma subtyping. AREX provides high-quality IHC raw antibodies supporting detection of epithelial differentiation and tumor markers to facilitate precise subtype classification and diagnostic platform development for lung diseases such as non-small cell lung cancer.
Core Advantages:
High specificity and low background suited to the complex staining environment of alveolar and bronchial tissue
Good sensitivity meeting needs across different histological subtypes
Excellent batch-to-batch consistency for large-scale OEM supply
AREX lung pathology raw antibodies integrate seamlessly with our
ARExVisual® micropolymer detection system and
Ancillaries supporting reagents to deliver a complete IHC solution.
Contact us to request catalogs, sample testing, or technical consultation.
Product List
